Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Human POLI Polyclonal Antibody

Catalog #:   PHK49701 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: Q9UNA4
Overview

Catalog No.

PHK49701

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human POLI (Arg53-Lys439).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

RAD30 homolog B, RAD30B, DNA polymerase iota, Eta2, POLI

Purification

Purified by antigen affinity column.

Accession

Q9UNA4

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN-BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with POLI antibody (PHK49701) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 46 kDa
    Observed MW: 46 kDa
  • Western Blot
    Various lysates were subjected to SDS PAGE followed by western blot with POLI antibody (PHK49701) at 1 μg/ml.

    Lane 1: Hela

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 83 kDa
    Observed MW: 83 kDa
  • Immunohistochemical
    Immunohistochemical analysis of rat liver stained for POLI with PHK49701.
References

Beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies., PMID:40407991

Long-term effects of COVID-19 in patients with primary immunodeficiency: An IPOPI worldwide survey., PMID:40316182

Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study., PMID:39986309

In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis., PMID:39742283

Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry., PMID:39660556

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study., PMID:39581202

The Latin American Society for Immunodeficiencies Registry., PMID:39436497

Analysis of translesion polymerases in colorectal cancer cells following cetuximab treatment: A network perspective., PMID:39102671

Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review., PMID:38936417

A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia., PMID:38806478

A Preliminary Evaluation of the Prognostic Role of HER-2 and HER-3 Immunohistochemical Expression in Canine Melanomas., PMID:38791617

5-chloro-3-(2-(2,4-dinitrophenyl) hydrazono)indolin-2-one: synthesis, characterization, biochemical and computational screening against SARS-CoV-2., PMID:38685970

Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence., PMID:38557303

Natural history of anti-PF 4 antibodies in patients with vaccine-induced immune thrombocytopenia and thrombosis., PMID:38315531

Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine., PMID:38078840

Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial., PMID:37949086

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency., PMID:37938781

Cerebral venous sinus thrombosis and thrombocytopenia due to heparin-independent anti-PF4 antibodies after adenovirus infection., PMID:37881869

Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19., PMID:37434312

Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries., PMID:37277922

A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients., PMID:37243116

No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke., PMID:37000850

Recurrent Acute Disseminated Encephalomyelitis (ADEM) after COVID-19-vaccination and after subsequent COVID-19-infection: A case report (part II)., PMID:36970530

Cladribine treatment specifically affects peripheral blood memory B cell clones and clonal expansion in multiple sclerosis patients., PMID:36960053

First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Rα., PMID:36734626

Immunohistochemical Characterization of Immune System Cells in Lymphoid Organs from Roe and Fallow Deer., PMID:36359187

Toxoplasmosis in Captive Ring-Tailed Lemurs (Lemur catta)., PMID:36297199

Deep immunophenotyping reveals biomarkers of multisystemic inflammatory syndrome in children in a Latin American cohort., PMID:36116582

Association of Microglial Activation With Spontaneous ARIA-E and CSF Levels of Anti-Aβ Autoantibodies., PMID:35940900

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19., PMID:35908040

Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness., PMID:35813575

Multiple Autoimmune Syndromes Including Acute Disseminated Encephalomyelitis, Myasthenia Gravis, and Thyroiditis Following Messenger Ribonucleic Acid-Based COVID-19 Vaccination: A Case Report., PMID:35711270

Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Multicenter Randomized Phase II Trial., PMID:35695006

Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 Vaccination., PMID:35689346

Transfer of continuous manufacturing process principles for mAb production in a GMP environment: A step in the transition from batch to continuous., PMID:35412696

Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C., PMID:35360001

BROLUCIZUMAB - A NEW PLAYER IN THE FIELD OF ANTI-VEGF THERAPY OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. A REVIEW., PMID:35300497

Achieving virological control in pan-resistant HIV-1 infection: A case series., PMID:35255457

Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts., PMID:35181688

AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper., PMID:35152450

An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity., PMID:35148840

Screening for preclinical parenchymal lung disease in rheumatoid arthritis., PMID:34875040

SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response., PMID:34749573

Pathological Features and Molecular Phenotype of MMTV Like-Positive Feline Mammary Carcinomas., PMID:34679842

SARS-COV-2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications., PMID:34569101

Autoantibody profiling of alveolar rhabdomyosarcoma patients unveils tumor-associated antigens with diagnostic and prognostic significance., PMID:34367733

BCL6 BTB-specific inhibitor reversely represses T-cell activation, Tfh cells differentiation, and germinal center reaction in vivo., PMID:34287839

Geographic tongue clinical response in moderate-to-severe psoriatic patients undergoing secukinumab: a real-life, multicenter retrospective observational study., PMID:34281329

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study., PMID:34170486

Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus., PMID:33846459

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human POLI Polyclonal Antibody [PHK49701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only